Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.74 USD | +0.12% | +21.17% | +14.46% |
Mar. 22 | B. Riley Securities Adjusts Harrow Health's Price Target to $26 From $30, Maintains Buy Rating | MT |
Mar. 20 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 186M | Sales 2025 * | 261M | Capitalization | 450M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | 28M | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.72 x |
P/E ratio 2024 * |
-40.6
x | P/E ratio 2025 * |
17.8
x | Employees | 315 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.41% |
Latest transcript on Harrow, Inc.
1 day | +1.19% | ||
1 week | +21.01% | ||
Current month | +17.60% | ||
1 month | +8.80% | ||
3 months | +16.26% | ||
6 months | -11.41% | ||
Current year | +13.66% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 11-11-30 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Director/Board Member | 65 | Jan. 25 | |
Adrienne Graves
BRD | Director/Board Member | 69 | Jan. 25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 12.82 | +0.71% | 72 521 |
24-03-27 | 12.73 | +1.19% | 530,646 |
24-03-26 | 12.58 | +4.83% | 738,221 |
24-03-25 | 12 | +4.35% | 1,046,711 |
24-03-22 | 11.5 | +8.70% | 1,285,640 |
Delayed Quote OTC Markets, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.66% | 450M | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.55% | 210B | |
+1.11% | 210B | |
-6.75% | 201B | |
-3.51% | 157B |